Dreux Marlène, Boson Bertrand, Ricard-Blum Sylvie, Molle Jennifer, Lavillette Dimitri, Bartosch Birke, Pécheur Eve-Isabelle, Cosset Francois-Loïc
Université de Lyon, (UCB-Lyon1), IFR128, INSERM, U758, and Ecole Normale Supérieure de Lyon, Lyon, F-69007, France.
J Biol Chem. 2007 Nov 2;282(44):32357-69. doi: 10.1074/jbc.M705358200. Epub 2007 Aug 30.
Cell entry of hepatitis C virus (HCV) is strikingly linked to lipoproteins and their receptors. Particularly, high density lipoprotein (HDL) enhances infectivity of HCV by involving the lipid-transfer function of the scavenger receptor BI, a receptor for both HDL and HCV. Here, we demonstrate that apoC-I, an exchangeable apolipoprotein that predominantly resides in HDL, specifically enhances HCVcc and HCVpp infectivity and increases the fusion rates between viral and target membranes via a direct interaction with the HCV surface. We identify the hypervariable region 1, located at the N terminus of the HCV E2 glycoprotein, as an essential viral component that modulates apoC-I-mediated enhancement of HCV fusion properties. The affinity of apoC-I for the HCV membrane may predispose it for fusion with a target membrane via alterations of its outer phospholipid layer. Conversely, we found that excess apoC-I provided as lipoprotein-free protein induces the disruption of the HCV membrane and subsequent loss of infectivity. Furthermore, our data indicate that HDL neither interacts nor spontaneously exchanges apoC-I with HCV virions. Because apoC-I is not present in serum as a lipoprotein-free form, our results suggest that HDL-embedded apoC-I could be released from the lipoprotein particle through a fine-tuned mechanism regulated via a triple interplay between hypervariable region 1, HDL, and scavenger receptor BI, resulting in optimal apoC-I recruitment on the viral membrane. These results provide the first description of a host serum factor helping the fusion process of an enveloped virus.
丙型肝炎病毒(HCV)的细胞进入与脂蛋白及其受体密切相关。特别是,高密度脂蛋白(HDL)通过清道夫受体BI(一种HDL和HCV的受体)的脂质转运功能增强了HCV的感染性。在这里,我们证明apoC-I(一种主要存在于HDL中的可交换载脂蛋白)通过与HCV表面直接相互作用,特异性增强HCVcc和HCVpp的感染性,并提高病毒膜与靶膜之间的融合率。我们确定位于HCV E2糖蛋白N端的高变区1是调节apoC-I介导的HCV融合特性增强的关键病毒成分。apoC-I对HCV膜的亲和力可能使其通过改变其外磷脂层而易于与靶膜融合。相反,我们发现以无脂蛋白形式提供的过量apoC-I会导致HCV膜破裂并随后丧失感染性。此外,我们的数据表明HDL既不与HCV病毒粒子相互作用,也不会自发地与HCV病毒粒子交换apoC-I。由于apoC-I在血清中不是以无脂蛋白形式存在,我们的结果表明,HDL包埋的apoC-I可以通过高变区1、HDL和清道夫受体BI之间的三重相互作用调节的微调机制从脂蛋白颗粒中释放出来,从而使apoC-I在病毒膜上实现最佳募集。这些结果首次描述了一种宿主血清因子有助于包膜病毒的融合过程。